Jones Financial Companies
TRAW icon

Jones Financial Companies’s Traws Pharma TRAW Stock Holding History

Jones Financial Companies’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4 Buy
+2
New +$4 ﹤0.01% 4714

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jones Financial Companies's TRAW Position: Q1 2026 in Review

Jones Financial Companies opened a new position in Traws Pharma (TRAW) in Q1 2026: 2 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #4714 among its holdings.

28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Jones Financial Companies held 2 shares of Traws Pharma worth $4 as of Q1 2026.
  • Traws Pharma was a new Jones Financial Companies position in Q1 2026.
  • Traws Pharma made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4714 holding.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.